SEC Form 4 · accession 0001645627-18-000017
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 22, 2018
Accepted (ET)
Mar 27, 2018 · 3:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2018 | P | 1,000 | $0.0378 | A | 24,893,689 | D | |
| Common Stock | Mar 23, 2018 | P | 1,000 | $0.0371 | A | 24,894,689 | D | |
| Common Stock | Mar 23, 2018 | P | 1,000 | $0.037 | A | 24,895,689 | D | |
| Common Stock | Mar 23, 2018 | P | 1,000 | $0.0365 | A | 24,896,689 | D | |
| Common Stock | Mar 26, 2018 | P | 1,000 | $0.036 | A | 24,897,689 | D | |
| Common Stock | Mar 26, 2018 | P | 1,000 | $0.034 | A | 24,898,689 | D | |
| Common Stock | Mar 26, 2018 | P | 1,000 | $0.034 | A | 24,899,689 | D | |
| Common Stock | Mar 26, 2018 | P | 1,000 | $0.034 | A | 24,900,689 | D | |
| Common Stock | Mar 26, 2018 | P | 1,000 | $0.034 | A | 24,901,689 | D | |
| Common Stock | Mar 26, 2018 | P | 2,000 | $0.034 | A | 24,903,689 | D |
Table II — derivative securities
No Table II lines on this filing.